These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

198 related articles for article (PubMed ID: 32757352)

  • 41. Remdesivir and SARS-CoV-2: Structural requirements at both nsp12 RdRp and nsp14 Exonuclease active-sites.
    Shannon A; Le NT; Selisko B; Eydoux C; Alvarez K; Guillemot JC; Decroly E; Peersen O; Ferron F; Canard B
    Antiviral Res; 2020 Jun; 178():104793. PubMed ID: 32283108
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Polymerase-catalyzed synthesis of DNA from phosphoramidate conjugates of deoxynucleotides and amino acids.
    Adelfinskaya O; Terrazas M; Froeyen M; Marlière P; Nauwelaerts K; Herdewijn P
    Nucleic Acids Res; 2007; 35(15):5060-72. PubMed ID: 17652326
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Binding properties of selective inhibitors of P323L mutated RdRp of SARS-CoV-2: a combined molecular screening, docking and dynamics simulation study.
    Chinnamadhu A; Ramakrishnan J; Suresh S; Poomani K
    J Biomol Struct Dyn; 2024 May; 42(8):4283-4296. PubMed ID: 37301607
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Phosphoramidate prodrugs of 2'-C-methylcytidine for therapy of hepatitis C virus infection.
    Gardelli C; Attenni B; Donghi M; Meppen M; Pacini B; Harper S; Di Marco A; Fiore F; Giuliano C; Pucci V; Laufer R; Gennari N; Marcucci I; Leone JF; Olsen DB; MacCoss M; Rowley M; Narjes F
    J Med Chem; 2009 Sep; 52(17):5394-407. PubMed ID: 19725579
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Regiochemical Analysis of the ProTide Activation Mechanism.
    Glockzin KM; Narindoshvili T; Raushel FM
    Biochemistry; 2024 Jul; 63(14):1774-1782. PubMed ID: 38958242
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Synthesis and antiviral evaluation of phosphoramidate derivatives of (E)-5-(2-bromovinyl)-2'-deoxyuridine.
    Harris SA; McGuigan C; Andrei G; Snoeck R; De Clercq E; Balzarini J
    Antivir Chem Chemother; 2001 Sep; 12(5):293-300. PubMed ID: 11900348
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Anti-HCV, nucleotide inhibitors, repurposing against COVID-19.
    Elfiky AA
    Life Sci; 2020 May; 248():117477. PubMed ID: 32119961
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Discovery and Evaluation of Entry Inhibitors for SARS-CoV-2 and Its Emerging Variants.
    Acharya A; Pandey K; Thurman M; Klug E; Trivedi J; Sharma K; Lorson CL; Singh K; Byrareddy SN
    J Virol; 2021 Nov; 95(24):e0143721. PubMed ID: 34550770
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Amino acid phosphoramidate nucleotides as alternative substrates for HIV-1 reverse transcriptase.
    Adelfinskaya O; Herdewijn P
    Angew Chem Int Ed Engl; 2007; 46(23):4356-8. PubMed ID: 17443759
    [No Abstract]   [Full Text] [Related]  

  • 50. A method for quantitating the intracellular metabolism of AZT amino acid phosphoramidate pronucleotides by capillary high-performance liquid chromatography-electrospray ionization mass spectrometry.
    Kim J; Park S; Tretyakova NY; Wagner CR
    Mol Pharm; 2005; 2(3):233-41. PubMed ID: 15934784
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Synthesis and anti-herpetic activity of phosphoramidate ProTides.
    Maiti M; Persoons L; Andrei G; Snoeck R; Balzarini J; Herdewijn P
    ChemMedChem; 2013 Jun; 8(6):985-93. PubMed ID: 23606629
    [TBL] [Abstract][Full Text] [Related]  

  • 52. ProTides of BVdU as potential anticancer agents upon efficient intracellular delivery of their activated metabolites.
    Kandil S; Balzarini J; Rat S; Brancale A; Westwell AD; McGuigan C
    Bioorg Med Chem Lett; 2016 Dec; 26(23):5618-5623. PubMed ID: 27818111
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Dual pro-drugs of 2'-C-methyl guanosine monophosphate as potent and selective inhibitors of hepatitis C virus.
    McGuigan C; Madela K; Aljarah M; Gilles A; Battina SK; Ramamurty CV; Srinivas Rao C; Vernachio J; Hutchins J; Hall A; Kolykhalov A; Henson G; Chamberlain S
    Bioorg Med Chem Lett; 2011 Oct; 21(19):6007-12. PubMed ID: 21856153
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Remdesivir MD Simulations Suggest a More Favourable Binding to SARS-CoV-2 RNA Dependent RNA Polymerase Mutant P323L Than Wild-Type.
    Mohammad A; Al-Mulla F; Wei DQ; Abubaker J
    Biomolecules; 2021 Jun; 11(7):. PubMed ID: 34206274
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Prolinyl Phosphoramidates of Nucleotides with Increased Reactivity.
    Humboldt A; Rami F; Topp FM; Arnold D; Göhringer D; Pallan PS; Egli M; Richert C
    Angew Chem Int Ed Engl; 2024 Apr; 63(15):e202319958. PubMed ID: 38300702
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Stereochemical influence on lipase-mediated hydrolysis and biological activity of stampidine and other stavudine phosphoramidates.
    Venkatachalam TK; Samuel P; Uckun FM
    Bioorg Med Chem; 2005 Mar; 13(5):1763-73. PubMed ID: 15698793
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Pharmacokinetics and tissue distribution of remdesivir and its metabolites nucleotide monophosphate, nucleotide triphosphate, and nucleoside in mice.
    Hu WJ; Chang L; Yang Y; Wang X; Xie YC; Shen JS; Tan B; Liu J
    Acta Pharmacol Sin; 2021 Jul; 42(7):1195-1200. PubMed ID: 33041326
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Favipiravir, remdesivir, and lopinavir: metabolites, degradation products and their analytical methods.
    Hoseininezhad-Namin MS; Rahimpour E; Jouyban A
    Drug Metab Rev; 2024; 56(2):127-144. PubMed ID: 38445647
    [TBL] [Abstract][Full Text] [Related]  

  • 59. The folate antagonist methotrexate diminishes replication of the coronavirus SARS-CoV-2 and enhances the antiviral efficacy of remdesivir in cell culture models.
    Stegmann KM; Dickmanns A; Gerber S; Nikolova V; Klemke L; Manzini V; Schlösser D; Bierwirth C; Freund J; Sitte M; Lugert R; Salinas G; Meister TL; Pfaender S; Görlich D; Wollnik B; Groß U; Dobbelstein M
    Virus Res; 2021 Sep; 302():198469. PubMed ID: 34090962
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Mapping the effect of drugs on ACE2 as a novel target site for COVID-19 therapy.
    Hetta HF; Muhammad K; Algammal AM; Ramadan H; Abdel-Rahman MS; Mabrok M; Koneru G; Elkady AA; El-Saber Batiha G; Waheed Y; Munawar N; Farghaly HSM
    Eur Rev Med Pharmacol Sci; 2021 May; 25(10):3923-3932. PubMed ID: 34109607
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.